![Radhika Tripuraneni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 756 800 $ au 31/07/2026
Radhika Tripuraneni is currently Chief Medical Officer at Viridian Therapeutics, Inc. since 2025.
Former positions include Independent Director at Terns Pharmaceuticals, Inc. from 2022 to 2026; Vice President-Medical Affairs at Alexion Pharmaceuticals, Inc.; Chief Medical Officer at Summer Street Research Partners; Vice President-Medical Affairs at MyoKardia, Inc. from 2017 to 2018; Vice President-Medical Affairs at Synageva BioPharma Corp.
from 2012 to 2017; and Chief Development Officer at Prothena Corp.
Plc from 2018 to 2022.
Education includes graduate studies at Harvard University and undergraduate and doctorate degrees from the University of Missouri.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/08/2026 | 40 000 ( 0,04% ) | 756 800 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/05/2026 |
| PROTHENA CORPORATION PLC | Corporate Officer/Principal | 01/09/2022 |
| MYOKARDIA, INC. | Corporate Officer/Principal | 01/03/2018 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01/01/2017 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Summer Street Research Partners
 Summer Street Research Partners Investment Banks/BrokersFinance Provides brokerage services | Finance |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
